Go Pro
NASDAQ:NNOX

Nano-X Imaging (NNOX) Stock Price, News & Analysis

Nano-X Imaging logo
$0.64 -0.03 (-4.02%)
Closing price 04:00 PM Eastern
Extended Trading
$0.63 -0.01 (-1.37%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Nano-X Imaging Stock (NASDAQ:NNOX)

Advanced

Key Stats

Today's Range
$0.63
▼
$0.69
50-Day Range
$0.63
▼
$1.11
52-Week Range
$0.63
▼
$4.71
Volume
822,535 shs
Average Volume
1.43 million shs
Market Capitalization
$49.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.33
Consensus Rating
Moderate Buy

Company Overview

Nano-X Imaging Ltd. (NASDAQ:NNOX) is an Israeli medical technology company focused on expanding access to diagnostic imaging. The company develops digital X-ray systems and related software intended to provide affordable, digitally managed imaging services for hospitals, clinics, and other healthcare providers.

Its principal platform, Nanox.ARC, is a digital X-ray system designed around a proprietary cold-cathode X-ray source and a multi-source imaging architecture. The company also offers Nanox.CLOUD, a cloud-based platform intended to connect imaging devices with radiologists and healthcare networks, and Nanox.AI, software designed to assist with the detection and prioritization of findings in medical images.

Nano-X markets its technologies to customers and partners in multiple international markets, with regulatory clearances and commercial availability varying by product and jurisdiction. The company was founded in 2012 and is headquartered in Israel. Its strategy combines imaging hardware, artificial-intelligence software, and cloud-based services to support medical imaging in regions where access to conventional imaging equipment and specialist interpretation may be limited.

AI Generated. May Contain Errors.

Nano-X Imaging Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

NNOX MarketRank™: 

Nano-X Imaging scored higher than 69% of companies evaluated by MarketBeat, and ranked 214th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nano-X Imaging has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 2 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Nano-X Imaging has a consensus price target of $4.33, representing about 581.7% upside from its current price of $0.64.

  • Amount of Analyst Coverage

    Nano-X Imaging has only been the subject of 3 research reports in the past 90 days.

  • Read more about Nano-X Imaging's stock forecast and price target.
  • Earnings Growth

    Earnings for Nano-X Imaging are expected to grow in the coming year, from ($1.23) to ($0.41) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nano-X Imaging is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nano-X Imaging is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nano-X Imaging has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Nano-X Imaging's valuation and earnings.
  • Percentage of Shares Shorted

    9.32% of the float of Nano-X Imaging has been sold short.
  • Short Interest Ratio / Days to Cover

    Nano-X Imaging has a short interest ratio ("days to cover") of 3.36, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nano-X Imaging has recently increased by 4.64%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Nano-X Imaging does not currently pay a dividend.

  • Dividend Growth

    Nano-X Imaging does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Nano-X Imaging this week, compared to 6 articles on an average week.
  • MarketBeat Follows

    12 people have added Nano-X Imaging to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • Cluster Insider Buying

    2 insiders have purchased shares of Nano-X Imaging in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $150,006.00 in company stock, which represents 0.3003% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Nano-X Imaging insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,006.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    7.74% of the stock of Nano-X Imaging is held by insiders.

  • Percentage Held by Institutions

    21.49% of the stock of Nano-X Imaging is held by institutions.

  • Read more about Nano-X Imaging's insider trading history.
Receive NNOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nano-X Imaging and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NNOX Stock News Headlines

How options let you do more with less capital
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.tc pixel
Nano-X Imaging Earnings Call: Growth Amid Heavy Losses
See More Headlines

NNOX Stock Analysis - Frequently Asked Questions

Nano-X Imaging's stock was trading at $2.80 at the beginning of 2026. Since then, NNOX shares have decreased by 77.3% and is now trading at $0.6357.

Nano-X Imaging Ltd. (NASDAQ:NNOX) posted its quarterly earnings data on Wednesday, September, 9th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.63. The business had revenue of $4.16 million for the quarter, compared to analyst estimates of $5.38 million. Nano-X Imaging had a negative trailing twelve-month return on equity of 116.93% and a negative net margin of 926.05%.
Read the conference call transcript
.

Nano-X Imaging (NNOX) raised $156 million in an initial public offering (IPO) on Friday, August 21st 2020. The company issued 9,178,744 shares at $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets acted as the underwriters for the IPO and National Securities Corp. was co-manager.

Shares of NNOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nano-X Imaging investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Bakkt (BKKT) and Virgin Galactic (SPCE).

Company Calendar

Last Earnings
9/09/2026
Today
10/02/2026
Next Earnings (Estimated)
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:NNOX
CIK
1795251
Employees
197
Year Founded
2011

Price Target and Rating

High Price Target
$5.00
Low Price Target
$3.00
Potential Upside/Downside
+581.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$75.02 million
Net Margins
-926.05%
Pretax Margin
-758.47%
Return on Equity
-116.93%
Return on Assets
-100.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.84
Quick Ratio
2.59

Sales & Book Value

Annual Sales
$13.02 million
Price / Sales
3.84
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.01 per share
Price / Book
0.32

Miscellaneous

Outstanding Shares
78,590,000
Free Float
72,506,000
Market Cap
$49.96 million
Optionable
Optionable
Beta
1.28

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:NNOX) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners